Introduction of a Board Benefit Trust (BBT) for Directors
First written in FY2020-Q2. 4 of 11 entries say "Advanced", first in FY2021-Q2. Latest entry: 2026-06-24.
40 other companies' latest entry also says "Advanced".
- 2026-06-24AdvancedGovernance
「The Board of Directors resolved to amend the scheme by adding the group executive officers and executive officers of the company, as well as the executive officers of the three core companies, to the eligible participants. The purpose is to make the linkage between the compensation of these officers and the company’s share value clearer, thereby strengthening their awareness of contributing to improved medium- to long-term performance and increased corporate value.」
The existing Board Benefit Trust (BBT) for directors and others was expanded to include the company’s group executive officers and executive officers and the executive officers of the three core companies. The maximum number of shares to be acquired was also specified as 822,000 shares for the initial target period and 897,000 shares for each subsequent 3-year business period. - FY2026AdvancedAnnual report
「At the 20th Annual General Meeting of Shareholders held on 24 June 2025, shareholders approved the proposals “Revision of Directors’ Compensation” and “Revision of the Share-Based Compensation Scheme for Directors.” Accordingly, at a meeting of the Company’s Board of Directors held after the conclusion of the general meeting of shareholders, the Company changed its “Policy on Directors’ Compensation at Seibu Holdings.”」
The directors’ compensation and share-based compensation schemes were revised to evaluate operating profit, ROE and segment operating profit for short-term compensation, and relative TSR, ESG metrics and non-financial KPIs for share-based compensation. - FY2026-H1AdvancedAnnual report
「At the 20th Annual General Meeting of Shareholders held on 24 June 2025, shareholders approved the proposals “Revision of Directors’ Compensation” and “Revision of the Share-Based Compensation Scheme for Directors.” Accordingly, at a meeting of the Company’s Board of Directors held after the conclusion of the general meeting of shareholders, the Company changed its “Policy on Directors’ Compensation at Seibu Holdings.”」
The Company revised its directors’ compensation and share-based compensation schemes. Short-term compensation is evaluated using operating profit, ROE and segment operating profit, among other metrics, while share-based compensation is evaluated using relative TSR, ESG metrics and non-financial KPIs. - FY2025-H1Decrease in shares remaining in the trustAnnual report
「The carrying amount and number of the Company’s shares remaining in the trust were ¥337 million and 197 thousand shares at the end of the previous consolidated fiscal year, and ¥289 million and 169 thousand shares at the end of the interim consolidated accounting period.」
The remaining shares under the Board Benefit Trust for directors decreased from 197 thousand shares at the end of the previous fiscal year to 169 thousand shares. - FY2023-Q3Decrease in shares remaining in the trustAnnual report
「The carrying amount and number of these treasury shares were ¥500 million and 292 thousand shares at the end of the previous consolidated fiscal year, and ¥424 million and 248 thousand shares at the end of the third quarter of the current consolidated fiscal year.」
The remaining shares under the Board Benefit Trust for directors decreased from 292 thousand shares at the end of the previous fiscal year to 248 thousand shares. - FY2023-Q2Decrease in shares remaining in the trustAnnual report
「The carrying amount and number of these treasury shares were ¥500 million and 292 thousand shares at the end of the previous consolidated fiscal year, and ¥424 million and 248 thousand shares at the end of the second quarter of the current consolidated fiscal year.」
The remaining shares under the Board Benefit Trust for directors decreased from 292 thousand shares at the end of the previous fiscal year to 248 thousand shares. - FY2023-Q1Decrease in shares remaining in the trustAnnual report
「The carrying amount and number of these treasury shares were ¥500 million and 292 thousand shares at the end of the previous consolidated fiscal year, and ¥476 million and 278 thousand shares at the end of the first quarter of the current consolidated fiscal year.」
The remaining shares under the Board Benefit Trust for directors decreased from 292 thousand shares at the end of the previous fiscal year to 278 thousand shares. - FY2022-Q1Decrease in shares remaining in the trustAnnual report
「The carrying amount and number of these treasury shares were ¥525 million and 307 thousand shares at the end of the previous consolidated fiscal year, and ¥500 million and 292 thousand shares at the end of the first quarter of the current consolidated fiscal year.」
The remaining shares under the Board Benefit Trust for directors decreased from 307 thousand shares at the end of the previous fiscal year to 292 thousand shares. - FY2021-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 26 May 2020, the Company resolved to add its subsidiary to the group of eligible participants in the scheme and revise the maximum amount of funds contributed for the acquisition of shares.」
For the BBT for directors, directors of a major subsidiary were added to the eligible participants, and the maximum amount of funds contributed for the acquisition of shares was revised. - FY2020-Q3RestatedAnnual report
「Under this share-based compensation scheme, the Company’s shares are acquired through a trust using funds contributed by the Company. In accordance with the Company’s rules for the annual incentive and long-term incentive under its director share benefit plan, directors receive the Company’s shares and cash equivalent to the fair value of the Company’s shares through the trust, collectively referred to as the “Company’s shares, etc.”」
For the BBT for directors, the scheme comprising annual and long-term incentives has been reconfirmed. The remaining shares held in the trust are stated as ¥531 million and 310 thousand shares. - FY2020-Q2First statedAnnual report
「From the standpoint of strengthening corporate governance, the Company has implemented a transaction in which its own shares are delivered to directors, excluding outside directors, through a trust. The purpose is to clarify the linkage between directors’ compensation and medium- to long-term performance and shareholder value, and to further enhance directors’ motivation to contribute to maximising corporate and shareholder value. Based on a resolution at the 14th Annual General Meeting of Shareholders held on 21 June 2019, the Company introduced a Board Benefit Trust (BBT) as an executive compensation scheme.」
The Company introduced the BBT based on a resolution at the June 2019 general meeting of shareholders, to strengthen the linkage between directors’ compensation and medium- to long-term performance and shareholder value. It comprises an annual incentive during the director’s term of office and a long-term incentive payable upon retirement.